Mayer L - Search Results

1

Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis.

Hu Y, Bally M, Dragowska WH, Mayer L. Hu Y, et al. Among authors: mayer l. Mol Cancer Ther. 2003 Jul;2(7):641-9. Mol Cancer Ther. 2003. PMID: 12883037

2

Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer.

Hu Y, Dragowska WH, Wallis A, Duronio V, Mayer L. Hu Y, et al. Among authors: mayer l. Breast Cancer Res Treat. 2001 Nov;70(1):11-20. doi: 10.1023/a:1012564620853. Breast Cancer Res Treat. 2001. PMID: 11767000

3

Combined treatment of Bcl-2 antisense oligodeoxynucleotides (G3139), p-glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug-resistant growth of drug-resistant breast cancer in severely combined immunodeficient mice.

Lopes de Menezes DE, Hu Y, Mayer LD. Lopes de Menezes DE, et al. J Exp Ther Oncol. 2003 Mar-Apr;3(2):72-82. doi: 10.1046/j.1359-4117.2003.01075.x. J Exp Ther Oncol. 2003. PMID: 12822513

4

Tumor chemosensitization strategies based on apoptosis manipulations.

Shabbits JA, Hu Y, Mayer LD. Shabbits JA, et al. Mol Cancer Ther. 2003 Aug;2(8):805-13. Mol Cancer Ther. 2003. PMID: 12939471 Review. No abstract available.

5

Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression.

Chi KC, Wallis AE, Lee CH, De Menezes DL, Sartor J, Dragowska WH, Mayer LD. Chi KC, et al. Among authors: mayer ld. Breast Cancer Res Treat. 2000 Oct;63(3):199-212. doi: 10.1023/a:1017371013487. Breast Cancer Res Treat. 2000. PMID: 11110054

6

Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.

Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Durkin JP, Mayer LD, LaCasse EC. Hu Y, et al. Clin Cancer Res. 2003 Jul;9(7):2826-36. Clin Cancer Res. 2003. PMID: 12855663

7

Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer model.

Waterhouse DN, Dragowska WH, Gelmon KA, Mayer LD, Bally MB. Waterhouse DN, et al. Cancer Biol Ther. 2004 Feb;3(2):197-204. Epub 2004 Feb 1. Cancer Biol Ther. 2004. PMID: 14726684

8

Synergistic cytotoxicity of pyrazoloacridine with doxorubicin, etoposide, and topotecan in drug-resistant tumor cells.

Hu Y, Krishan A, Nie W, Sridhar KS, Mayer LD, Bally M. Hu Y, et al. Clin Cancer Res. 2004 Feb 1;10(3):1160-9. doi: 10.1158/1078-0432.ccr-1044-3. Clin Cancer Res. 2004. PMID: 14871996

9

Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer.

Hu Y, Bebb G, Tan S, Ng R, Yan H, Sartor JR, Mayer LD, Bally MB. Hu Y, et al. Clin Cancer Res. 2004 Nov 15;10(22):7662-70. doi: 10.1158/1078-0432.CCR-04-1036. Clin Cancer Res. 2004. PMID: 15569999

10

Prevention of antibody-mediated elimination of ligand-targeted liposomes by using poly(ethylene glycol)-modified lipids.

Li WM, Mayer LD, Bally MB. Li WM, et al. J Pharmacol Exp Ther. 2002 Mar;300(3):976-83. doi: 10.1124/jpet.300.3.976. J Pharmacol Exp Ther. 2002. PMID: 11861806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,163 results

Search Page

Filters